Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive bundle approach
American Journal of Infection Control, 11/10/09
Rodríguez–Baño J et al. – The implementation of a comprehensive and multifaceted infection control program in a tertiary care center effectively controlled the spread and clinical impact of MDR Ab.
Related Articles
Epidemiology and Impact of Imipenem Resistance in Acinetobacter baumannii
Infection Control and Hospital Epidemiology, 10/28/09
Relevance Score: 67%
Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre
Journal of Medical Microbiology, 10/22/09
Relevance Score: 67%
Acinetobacter baumannii-Associated Skin and Soft Tissue Infections: Recognizing a Broadening Spectrum of Disease
Surgical Infections, 10/02/09
Relevance Score: 67%
Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature
International Journal of Infectious Diseases, 11/16/09
Relevance Score: 66%
Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii
Journal of Clinical Microbiology, 11/02/09
Relevance Score: 66%
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years
The Lancet, 12/15/09
Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy
Journal of the National Cancer Institute, 12/15/09
Associations between HLA Class I Alleles and Escape Mutations in the Hepatitis B Virus Core Gene in New Zealand-Resident Tongans
Journal of Virology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


